REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 32 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,663,000 | +721.9% | 5,222,073 | +128.4% | 0.00% | – |
Q4 2016 | $324,000 | -68.7% | 2,286,623 | -53.6% | 0.00% | – |
Q3 2016 | $1,035,000 | -16.0% | 4,927,397 | +0.5% | 0.00% | – |
Q2 2016 | $1,232,000 | -23.1% | 4,904,097 | +1.0% | 0.00% | – |
Q1 2016 | $1,602,000 | -9.9% | 4,854,336 | -0.9% | 0.00% | – |
Q4 2015 | $1,778,000 | -29.6% | 4,898,122 | +0.8% | 0.00% | – |
Q3 2015 | $2,527,000 | -13.7% | 4,860,087 | +0.8% | 0.00% | – |
Q2 2015 | $2,929,000 | -13.7% | 4,819,441 | +3.7% | 0.00% | – |
Q1 2015 | $3,394,000 | +11.8% | 4,649,423 | +7.2% | 0.00% | – |
Q4 2014 | $3,037,000 | -8.7% | 4,338,622 | +5.7% | 0.00% | – |
Q3 2014 | $3,325,000 | +6.9% | 4,105,784 | +14.9% | 0.00% | – |
Q2 2014 | $3,109,000 | -19.0% | 3,574,300 | +0.6% | 0.00% | – |
Q1 2014 | $3,839,000 | +280.5% | 3,554,400 | +79.6% | 0.00% | – |
Q4 2013 | $1,009,000 | +13.4% | 1,978,577 | 0.0% | 0.00% | – |
Q3 2013 | $890,000 | +156.5% | 1,978,577 | +153.2% | 0.00% | – |
Q2 2013 | $347,000 | – | 781,357 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
Benin Management CORP | 83,000 | $61,000 | 0.03% |
First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
WFG Advisors, LP | 3,500 | $3,000 | 0.00% |